Tasly Pharmaceutical Group Co., Ltd (SHA:600535)
China
· Delayed Price · Currency is CNY 15.35
+0.03 (0.20%)
Dec 5, 2025, 3:00 PM CST
SHA:600535 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 4, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 22,932 | 21,603 | 25,427 | 15,988 | 23,778 | 22,302 | Upgrade
|
| Market Cap Growth | -1.98% | -15.04% | 59.04% | -32.76% | 6.62% | -4.09% | Upgrade
|
| Enterprise Value | 20,496 | 19,116 | 24,806 | 15,103 | 23,396 | 23,975 | Upgrade
|
| Last Close Price | 15.35 | 14.08 | 15.84 | 9.80 | 13.98 | 12.74 | Upgrade
|
| PE Ratio | 20.76 | 22.61 | 23.74 | - | 10.08 | 19.81 | Upgrade
|
| Forward PE | 13.18 | 15.72 | 7.47 | 4.03 | 8.30 | 12.53 | Upgrade
|
| PS Ratio | 2.75 | 2.54 | 2.93 | 1.85 | 2.99 | 1.64 | Upgrade
|
| PB Ratio | 1.83 | 1.78 | 2.00 | 1.26 | 1.79 | 1.80 | Upgrade
|
| P/TBV Ratio | 1.99 | 1.91 | 2.16 | 1.34 | 1.93 | 1.92 | Upgrade
|
| P/FCF Ratio | 18.55 | 14.90 | 13.34 | 8.53 | 10.67 | 16.13 | Upgrade
|
| P/OCF Ratio | 13.51 | 10.72 | 9.87 | 7.01 | 8.49 | 12.45 | Upgrade
|
| PEG Ratio | 1.10 | 1.80 | 1.80 | 1.80 | 1.80 | 1.80 | Upgrade
|
| EV/Sales Ratio | 2.46 | 2.25 | 2.86 | 1.75 | 2.94 | 1.77 | Upgrade
|
| EV/EBITDA Ratio | 12.23 | 10.43 | 12.75 | 8.51 | 14.20 | 12.44 | Upgrade
|
| EV/EBIT Ratio | 16.10 | 13.31 | 17.22 | 11.27 | 18.83 | 17.28 | Upgrade
|
| EV/FCF Ratio | 16.58 | 13.19 | 13.01 | 8.05 | 10.49 | 17.34 | Upgrade
|
| Debt / Equity Ratio | 0.07 | 0.14 | 0.22 | 0.17 | 0.13 | 0.23 | Upgrade
|
| Debt / EBITDA Ratio | 0.51 | 0.87 | 1.46 | 1.17 | 0.98 | 1.45 | Upgrade
|
| Debt / FCF Ratio | 0.69 | 1.15 | 1.49 | 1.16 | 0.76 | 2.02 | Upgrade
|
| Asset Turnover | 0.53 | 0.54 | 0.52 | 0.52 | 0.48 | 0.67 | Upgrade
|
| Inventory Turnover | 1.75 | 1.62 | 1.76 | 2.04 | 1.85 | 4.16 | Upgrade
|
| Quick Ratio | 3.07 | 2.34 | 2.91 | 3.54 | 4.10 | 2.73 | Upgrade
|
| Current Ratio | 3.83 | 3.11 | 3.69 | 4.31 | 4.99 | 3.26 | Upgrade
|
| Return on Equity (ROE) | 8.02% | 6.93% | 8.02% | -2.68% | 18.74% | 8.99% | Upgrade
|
| Return on Assets (ROA) | 5.01% | 5.66% | 5.43% | 5.08% | 4.70% | 4.28% | Upgrade
|
| Return on Capital (ROIC) | 5.58% | 6.13% | 5.93% | 5.61% | 5.14% | 4.93% | Upgrade
|
| Return on Capital Employed (ROCE) | 9.90% | 11.40% | 10.00% | 9.40% | 8.50% | 10.20% | Upgrade
|
| Earnings Yield | 4.79% | 4.42% | 4.21% | -1.65% | 9.92% | 5.05% | Upgrade
|
| FCF Yield | 5.39% | 6.71% | 7.50% | 11.73% | 9.38% | 6.20% | Upgrade
|
| Dividend Yield | 3.45% | 3.76% | 2.08% | 3.37% | 2.36% | 2.59% | Upgrade
|
| Payout Ratio | 75.77% | 109.09% | 52.59% | - | 25.88% | 70.99% | Upgrade
|
| Buyback Yield / Dilution | 0.60% | -0.43% | -1.34% | 2.29% | -0.08% | 1.06% | Upgrade
|
| Total Shareholder Return | 4.06% | 3.34% | 0.75% | 5.66% | 2.27% | 3.65% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.